Momenta Pharmaceuticals, Inc. (MNTA) stock prices updated...
 

Momenta Pharmaceuticals, Inc. stock price

Momenta Pharmaceuticals, Inc. latest news:


  • 02/12/2018 23:22:28

    BRIEF-Momenta Pharmaceuticals Announces FDA Approval And Launch Of Glatopa

    * MOMENTA PHARMACEUTICALS ANNOUNCES FDA APPROVAL AND LAUNCH OF GLATOPA® (GLATIRAMER ACETATE INJECTION) 40 MG/ML

  • 01/03/2018 15:40:41

    Momenta, Mylan plan trial of biosimilar to Regeneron eye drug

    Jan 3 (Reuters) - Momenta Pharmaceuticals Inc and Mylan NV plan to begin a pivotal clinical trial of a biosimilar to Regeneron Pharmaceuticals Inc's blockbuster eye drug Eylea in the first half of this year, the two companies said on Wednesday.

  • More trends:

    Momo Inc.MOMO | Monarch Casino & Resort, Inc.MCRI | Monarch Financial Holdings, Inc.MNRK | Mondelez International, Inc.MDLZ | Moneygram International, Inc.MGI | Monolithic Power Systems, Inc.MPWR | Monotype Imaging Holdings Inc.TYPE | Monro Muffler Brake, Inc.MNRO | Monroe Capital CorporationMRCC | Monster Beverage CorporationMNST |